Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses
- PMID: 18683099
Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses
Abstract
Oncolytic viruses possess several key attributes that make them a highly attractive treatment for cancer. They exhibit clinically validated synergy with chemotherapy and an ability to selectively destroy tumor cells to the exclusion of normal cells. Oncolytic viruses can replicate and, therefore, amplify their dose in a tumor-dependent manner. In addition, they can be genetically manipulated to include additional therapeutic factors to create a multimodal anticancer agent. These characteristics lead to the expectation that oncolytic viruses will serve as an additional tool in the treatment repertoire of clinical oncologists. In their clinical development to date, these agents were safe and well tolerated, but lacked efficacy as monotherapies. In this review, three genetic-based methods to increase the potency and efficacy of oncolytic viruses, in which human adenovirus is utilized as an example of a prototype oncolytic virus, are discussed.
Similar articles
-
Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.Arch Immunol Ther Exp (Warsz). 2008 Dec;56 Suppl 1:3s-59s. doi: 10.1007/s00005-008-0047-9. Epub 2008 Dec 23. Arch Immunol Ther Exp (Warsz). 2008. PMID: 19104757 Review.
-
Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.Gene Ther. 2006 Apr;13(8):705-14. doi: 10.1038/sj.gt.3302717. Gene Ther. 2006. PMID: 16421599
-
A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.Gene Ther. 2007 Apr;14(8):638-47. doi: 10.1038/sj.gt.3302914. Epub 2007 Feb 1. Gene Ther. 2007. PMID: 17268533
-
Virus combinations and chemotherapy for the treatment of human cancers.Curr Opin Mol Ther. 2008 Aug;10(4):371-9. Curr Opin Mol Ther. 2008. PMID: 18683102 Review.
-
Naturally oncolytic viruses.Curr Opin Mol Ther. 2006 Aug;8(4):314-21. Curr Opin Mol Ther. 2006. PMID: 16955694 Review.
Cited by
-
Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates.Mol Ther. 2010 Apr;18(4):754-65. doi: 10.1038/mt.2009.312. Epub 2010 Jan 19. Mol Ther. 2010. PMID: 20087317 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources